Rang	Name	Position
1	Mr. Milano Furuta	CFO & Director
2	Dr. Andrew S. Plump M.D., Ph.D.	President of Research & Development and Representative Director
3	Ms. Julie Kim	CEO, President & Director
4	Dr. Seigo Izumo	Chair of Management Board
5	Mr. Haruhiko Hirate	Member of Management Board
6	Mr. Salvatore Alesci M.D., Ph.D.	Member of Management Board and Head of R&D Global Science & Biomedical Policy
7	Michael Fox	Chief Operating Officer
8	Norimasa Takeda	Chief Accounting Officer & Corporate Controller
9	Mr. Iwaaki Taniguchi	Senior Vice President of Corporate Finance & Controlling Department
10	Mr. Gabriele Ricci	Chief Data & Technology Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Capital Research Global Investors	0,61%	0,36 Mrd. USD
2	FMR Inc	0,23%	0,13 Mrd. USD
3	Morgan Stanley - Brokerage Accounts	0,20%	0,12 Mrd. USD
4	Adage Capital Partners Gp LLC	0,19%	0,11 Mrd. USD
5	The Goldman Sachs Group Inc	0,18%	0,10 Mrd. USD
6	Brandes Investment Partners & Co	0,14%	0,08 Mrd. USD
7	BlackRock Inc	0,10%	0,06 Mrd. USD
8	Arrowstreet Capital Limited Partnership	0,10%	0,06 Mrd. USD
9	Renaissance Technologies Corp	0,09%	0,06 Mrd. USD
10	UBS Group AG	0,09%	0,05 Mrd. USD
11	Van Eck Associates Corporation	0,07%	0,04 Mrd. USD
12	First Trust Advisors L.P.	0,07%	0,04 Mrd. USD
13	D. E. Shaw & Co LP	0,06%	0,04 Mrd. USD
14	Northern Trust Corp	0,06%	0,04 Mrd. USD
15	Managed Asset Portfolios, LLC	0,06%	0,03 Mrd. USD
16	Quantinno Capital Management LP	0,04%	0,02 Mrd. USD
17	Wells Fargo & Co	0,04%	0,02 Mrd. USD
18	Millennium Management LLC	0,03%	0,02 Mrd. USD
19	AQR Capital Management LLC	0,03%	0,02 Mrd. USD
20	Capital Wealth Planning, LLC	0,03%	0,02 Mrd. USD